Skip to content

High levels of adherence to study medication among women who conceived during HIV PrEP study

PrEP users say it provides an 'extra layer of protection' and 'peace of mind'

People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates

Daily dosing key to the efficacy of tenofovir-based HIV PrEP

New booklet from NAM: Taking your HIV treatment

New booklet from NAM: Taking your HIV treatment

Very different levels of PrEP uptake and adherence in three US cities, demonstration project finds

Higher pill burden is associated with poorer adherence to HIV therapy and reduced chances of achieving an undetectable viral load

Significant attrition at each step of the HIV care 'cascade' in British Columbia

Computerised counselling for patients taking HIV therapy can reduce viral load, improve treatment adherence and reduce rates of risky sex